Liposomal Amikacin for Treatment of M. avium Infections in Clinically Relevant Experimental Settings

This publication has 19 references indexed in Scilit:

• Mechanisms of granuioma formation in murine Mycobacterium avium infection: the contribution of CD4⁺ T cells
  International Immunology, 1996
• Liposomes in the Treatment of Infections
  Journal of Drug Targeting, 1994
• Survival of Patients with Acquired Immune Deficiency Syndrome and DisseminatedMycobacterium aviumComplex Infection with and without Antimycobacterial Chemotherapy
  American Review of Respiratory Disease, 1991
• Mycobacterium aviumComplex Infection in the Acquired Immunodeficiency Syndrome
  New England Journal of Medicine, 1991
• Treatment of Disseminated Mycobacterium avium Complex Infection of Beige Mice with Liposome-Encapsulated Aminoglycosides
  The Journal of Infectious Diseases, 1990
• The beige mouse model for mycobacterium avium complex (MAC) disease: Optimal conditions for the host and parasite
  Tubercle, 1989
• Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice
  Antimicrobial Agents and Chemotherapy, 1989
• Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice
  Antimicrobial Agents and Chemotherapy, 1988
• Free Versus Liposome-Entrapped Ampicillin in Treatment of Infection Due to Listeria monocytogenes in Normal and Atbymic (Nude) Mice
  The Journal of Infectious Diseases, 1985
• Editorial: A typical Mycobacterial Infections in Children
  Clinical Infectious Diseases, 1981